161 related articles for article (PubMed ID: 6607916)
1. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
Maskell JP; Nasu M; Williams JD
J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
Martin MA; Liebana J; Castillo AM; Gutierrez J; Piédrola G
Microbios; 1991; 67(272-273):195-202. PubMed ID: 1779879
[TBL] [Abstract][Full Text] [Related]
3. Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.
Lamothe F; Auger F; Lacroix JM
Antimicrob Agents Chemother; 1984 May; 25(5):662-5. PubMed ID: 6732233
[TBL] [Abstract][Full Text] [Related]
4. Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis.
Yotsuji A; Minami S; Kakizawa H; Yasuda T; Takai A; Saikawa I; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Dec; 28(6):773-7. PubMed ID: 3878690
[TBL] [Abstract][Full Text] [Related]
5. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
6. Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.
Lacroix JM; Lamothe F; Malouin F
Antimicrob Agents Chemother; 1984 Nov; 26(5):694-8. PubMed ID: 6335019
[TBL] [Abstract][Full Text] [Related]
7. The effect of clavulanic acid on the susceptibility of Bacteroides fragilis to three acyl-ureidopenicillins, ampicillin and carbenicillin.
Simpson CN; Maskell JP; Williams JD
J Antimicrob Chemother; 1984 Aug; 14(2):133-8. PubMed ID: 6334069
[TBL] [Abstract][Full Text] [Related]
8. The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group.
Malouin F; Lamothe F
Can J Microbiol; 1987 Mar; 33(3):262-6. PubMed ID: 3105858
[TBL] [Abstract][Full Text] [Related]
9. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
Eley A; Greenwood D
J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
[TBL] [Abstract][Full Text] [Related]
10. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Fuchs PC; Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
[TBL] [Abstract][Full Text] [Related]
11. Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.
Aldridge KE
Diagn Microbiol Infect Dis; 1993 Oct; 17(3):251-6. PubMed ID: 8112038
[TBL] [Abstract][Full Text] [Related]
12. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
de Barbeyrac B; Quentin C; Bebear C
Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
15. The activity of ticarcillin in combination with clavulanic acid against Bacteroides species: an in-vitro comparison with other antibiotics.
de Barbeyrac B; Quentin C; Bébéar C
J Antimicrob Chemother; 1986 May; 17 Suppl C():35-9. PubMed ID: 3636337
[TBL] [Abstract][Full Text] [Related]
16. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
Aldridge KE; Henderberg A; Sanders CV
J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
[TBL] [Abstract][Full Text] [Related]
17. Characterization of beta-lactamases in clinical isolates of Bacteroides.
Eley A; Greenwood D
J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Downes J; Andrew JH
Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
[TBL] [Abstract][Full Text] [Related]
19. Variations in susceptibility to latamoxef(moxalactam) and cefoxitin within the Bacteroides fragilis group.
Eley A; Greenwood D
J Antimicrob Chemother; 1984 Mar; 13(3):245-55. PubMed ID: 6725175
[TBL] [Abstract][Full Text] [Related]
20. Studies on beta-lactamase in Bacteroides fragilis.
Nord CE; Dornbusch K; Olsson B
Infection; 1980; 8 Suppl 2():S167-70. PubMed ID: 6969692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
